dostarlimab
gsk
[]
 although encouraged by the progress in msi-h disease, am hard pressed to deny resection in proper candidate if can be done with acceptable morbidity. pet scans can be unreliable after tx and biopsies have sampling errors. discordant responses seen among lesions (particularly lns)
Hedinger Chair of Surgical Oncology @OHSUsurgery | Physician-in-Chief @OHSUKnight |???? ???? ?? ?? ?? Tweet/RT/??=my own